REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $147,332 | -54.7% | 12,845 | 0.0% | 0.01% | -52.2% |
| Q2 2023 | $325,107 | -50.7% | 12,845 | -37.3% | 0.02% | -54.0% |
| Q1 2023 | $660,015 | +74.5% | 20,491 | 0.0% | 0.05% | +56.2% |
| Q4 2022 | $378,264 | -31.6% | 20,491 | 0.0% | 0.03% | -50.0% |
| Q3 2022 | $553,000 | +95.4% | 20,491 | 0.0% | 0.06% | +88.2% |
| Q2 2022 | $283,000 | -29.2% | 20,491 | 0.0% | 0.03% | -5.6% |
| Q1 2022 | $400,000 | +19.8% | 20,491 | 0.0% | 0.04% | +20.0% |
| Q4 2021 | $334,000 | -41.5% | 20,491 | 0.0% | 0.03% | -51.6% |
| Q3 2021 | $571,000 | -5.9% | 20,491 | 0.0% | 0.06% | 0.0% |
| Q2 2021 | $607,000 | +5.9% | 20,491 | 0.0% | 0.06% | -19.5% |
| Q1 2021 | $573,000 | -1.4% | 20,491 | 0.0% | 0.08% | -20.6% |
| Q4 2020 | $581,000 | – | 20,491 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |